# Ubiquinol (Reduced CoQ10)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/ubiquinol
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-04-01
**Evidence Score:** 2 / 10
**Category:** Other
**Also Known As:** Reduced Coenzyme Q10, Reduced CoQ10, CoQH2, Ubiquinol-10, Active CoQ10, Kaneka Ubiquinol, Reduced form ubiquinone, Coenzyme Q10H2

## Overview

Ubiquinol is the fully reduced, active [antioxidant](/ingredients/condition/antioxidant) form of Coenzyme Q10 (CoQ10), accounting for approximately 90% of total CoQ10 in healthy human plasma. It directly donates electrons within the [mitochondrial](/ingredients/condition/energy) electron transport chain at Complexes I, II, and III to drive ATP synthesis, while simultaneously neutralizing lipid peroxyl radicals in cell membranes and LDL particles.

## Health Benefits

• [Energy production](/ingredients/condition/energy) support through participation in mitochondrial electron transport chain (mechanism established, clinical evidence not provided)
• [Antioxidant protection](/ingredients/condition/antioxidant) preventing lipid peroxidation in cell membranes and LDL (mechanism established, clinical evidence not provided)
• Vitamin E regeneration through reduction of tocopheroxyl radical (mechanism established, clinical evidence not provided)
• Potential [cardiovascular](/ingredients/condition/heart-health) support through LDL oxidation prevention (mechanism established, clinical evidence not provided)
• Enhanced bioavailability compared to ubiquinone due to slightly increased water solubility (formulation studies noted, clinical outcomes not provided)

## Mechanism of Action

Ubiquinol (CoQH2) shuttles electrons between protein complexes in the inner [mitochondrial](/ingredients/condition/energy) membrane, transferring reducing equivalents from NADH and FADH2 via Complexes I and II to Complex III (ubiquinol-cytochrome c reductase), directly driving the proton gradient used by ATP synthase to phosphorylate ADP. As a lipid-soluble antioxidant, ubiquinol donates a hydrogen atom to peroxyl radicals (LOO•), terminating [lipid peroxidation](/ingredients/condition/antioxidant) chain reactions in biological membranes and LDL particles, and is regenerated from ubiquinone by NAD(P)H-dependent reductases. Additionally, ubiquinol recycles oxidized alpha-tocopherol (vitamin E) back to its active reduced form by donating an electron to the tocopheroxyl radical, amplifying the cellular antioxidant network.

## Clinical Summary

A randomized controlled trial in 420 patients with advanced heart failure (NYHA Class III–IV) — the Q-SYMBIO trial — found that 300 mg/day of CoQ10 (predominantly ubiquinol in plasma) reduced major adverse [cardiovascular](/ingredients/condition/heart-health) events by 43% and cardiovascular mortality by 43% compared to placebo over 2 years, though replication in larger trials is needed. Pharmacokinetic studies consistently demonstrate ubiquinol achieves roughly 2-fold greater peak plasma concentration (Cmax) than an equivalent dose of ubiquinone in healthy adults, supporting its use at lower doses for equivalent tissue saturation. Small randomized trials (n=20–50) in statin users show ubiquinol supplementation at 100–200 mg/day modestly attenuates statin-induced reductions in plasma CoQ10, but evidence that this translates to reduced myopathy symptoms remains inconsistent and under-powered. Evidence for [cognitive](/ingredients/condition/cognitive), exercise performance, and fertility benefits is preliminary, derived largely from small trials and observational studies, and should be considered hypothesis-generating rather than conclusive.

## Nutritional Profile

Ubiquinol (Reduced CoQ10) is a non-caloric bioactive compound, not a macronutrient source. It contains no protein, carbohydrates, fiber, or dietary fat in its pure form. The active compound is ubiquinol-10 (2,3-dimethoxy-5-methyl-6-decaprenyl-1,4-benzenediol), the fully reduced form of coenzyme Q10, typically standardized to 50–200 mg per serving in supplement form. Ubiquinol carries two hydroxyl groups (-OH) on its benzene ring, distinguishing it from ubiquinone (oxidized CoQ10), and exists in lipid membranes at endogenous plasma concentrations of approximately 0.40–1.91 µmol/L in healthy adults, comprising roughly 90–95% of total plasma CoQ10 in healthy individuals. As a fat-soluble molecule with a molecular weight of 882.5 g/mol, ubiquinol requires dietary fat for intestinal absorption. Bioavailability is notably superior to ubiquinone: studies indicate ubiquinol achieves approximately 2–4 times greater plasma concentration increases per equivalent dose compared to ubiquinone, attributed to its pre-reduced state eliminating the intestinal reduction step. Peak plasma levels (Cmax) are reached within 5–8 hours post-ingestion. Absorption occurs via chylomicron incorporation in the small intestine. No clinically significant vitamins or minerals are inherent to ubiquinol itself; its nutritional relevance is exclusively as a lipid-soluble redox-active quinone.

## Dosage & Preparation

No clinically studied dosage ranges for ubiquinol are specified in the research results. Bioavailability improvements are noted for solubilized formulations (liposomes, micelles, nanoemulsions) but specific doses are not provided. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Ubiquinol is well tolerated across clinical trials; the most commonly reported adverse effects are mild and gastrointestinal in nature, including nausea, diarrhea, and epigastric discomfort, typically at doses above 300 mg/day. Ubiquinol may potentiate the anticoagulant effect of warfarin or, paradoxically, reduce its efficacy due to its structural similarity to vitamin K — patients on warfarin should have INR monitored closely when initiating or discontinuing supplementation. HMG-CoA reductase inhibitors (statins), beta-blockers such as metoprolol, and tricyclic antidepressants are known to deplete endogenous CoQ10 levels, making ubiquinol supplementation potentially relevant in these populations. Safety data in pregnancy and lactation are insufficient to establish a recommended dose; use should be deferred to physician guidance, and the supplement is generally avoided in these populations absent a specific clinical indication.

## Scientific Research

The research dossier does not include specific clinical trials, RCTs, or meta-analyses for ubiquinol with PMIDs, study designs, or sample sizes. While general references note CoQ10's roles in [energy production](/ingredients/condition/energy) and [antioxidant](/ingredients/condition/antioxidant) defense, targeted clinical data for ubiquinol supplementation outcomes are absent from the provided research.

## Historical & Cultural Context

No historical context or traditional medicine uses for ubiquinol are described in the research results. Ubiquinol is primarily a modern biochemical focus rather than a traditional remedy, as it was identified through contemporary scientific understanding of cellular [energy metabolism](/ingredients/condition/energy).

## Synergistic Combinations

Vitamin E, PQQ, Alpha-lipoic acid, B-complex vitamins, Omega-3 fatty acids

## Frequently Asked Questions

### What is the difference between ubiquinol and ubiquinone?

Ubiquinol (CoQH2) is the fully reduced form of CoQ10 with two extra hydrogen atoms, giving it direct antioxidant activity, while ubiquinone (CoQ10) is the oxidized form that must be converted to ubiquinol in the body before it can act as an antioxidant. Pharmacokinetic studies show ubiquinol produces approximately 2-fold higher plasma CoQ10 levels than the same milligram dose of ubiquinone, making it particularly useful for older adults whose enzymatic conversion capacity declines with age.

### What is the recommended dosage of ubiquinol?

Most clinical trials investigating cardiovascular and antioxidant outcomes use ubiquinol or CoQ10 doses ranging from 100 mg to 300 mg per day, typically divided into two doses taken with fat-containing meals to maximize absorption. For general antioxidant and energy support, 100–200 mg/day is commonly studied, while the Q-SYMBIO heart failure trial used 300 mg/day in three divided 100 mg doses. Doses above 300 mg/day have not demonstrated proportionally greater benefits and increase the likelihood of gastrointestinal side effects.

### Can ubiquinol help with statin-induced muscle pain?

Statins inhibit the mevalonate pathway, which reduces endogenous synthesis of both cholesterol and CoQ10, leading to plasma CoQ10 reductions of 16–54% in some studies — a mechanism theorized to contribute to statin myopathy. While ubiquinol supplementation reliably restores plasma CoQ10 levels in statin users, randomized controlled trials examining muscle pain outcomes have produced inconsistent results, with several small trials (n=32–64) showing no statistically significant reduction in myalgia scores. Current evidence is insufficient for a definitive recommendation, but the favorable safety profile makes it a commonly trialed adjunct under physician supervision.

### Does ubiquinol improve energy levels?

Ubiquinol's role in ATP synthesis via the mitochondrial electron transport chain provides a mechanistic rationale for energy support, and plasma CoQ10 deficiency — seen in heart failure, aging, and with statin use — is associated with fatigue. However, in healthy individuals with normal CoQ10 status, clinical trials have not consistently demonstrated measurable improvements in subjective energy or exercise performance, suggesting benefit may be most relevant in those with depleted baseline levels. A meta-analysis of CoQ10 supplementation and exercise performance found modest improvements in maximal oxygen uptake (VO2 max) in some subgroups, but effect sizes were small and study quality was variable.

### Is ubiquinol safe to take with blood pressure medications?

Ubiquinol may have mild blood pressure-lowering effects; a meta-analysis of 17 trials reported average systolic reductions of approximately 11 mmHg and diastolic reductions of 7 mmHg with CoQ10 supplementation, though study quality was heterogeneous. When combined with antihypertensive medications such as ACE inhibitors, beta-blockers, or calcium channel blockers, there is a theoretical risk of additive hypotensive effects, making blood pressure monitoring advisable when initiating supplementation. Beta-blockers such as propranolol also inhibit CoQ10-dependent enzymes, making ubiquinol potentially relevant in this population, but dose adjustments to antihypertensives should only be made under medical supervision.

### How does ubiquinol absorption compare to ubiquinone, and what factors affect how much my body actually uses?

Ubiquinol is the reduced form of CoQ10 and is generally considered more bioavailable than ubiquinone because it doesn't require conversion in the body. Absorption of ubiquinol is enhanced when taken with dietary fats and may be compromised by age-related decline in metabolic function, certain medications, and digestive health status. Taking ubiquinol with meals containing healthy fats can significantly improve bioavailability compared to taking it on an empty stomach.

### Who would benefit most from ubiquinol supplementation, and are there specific populations who should avoid it?

Ubiquinol may be particularly beneficial for individuals over 40, those taking statin medications, people with mitochondrial disorders, and those with cardiovascular concerns, as CoQ10 levels naturally decline with age and certain treatments. Pregnant and breastfeeding women should consult healthcare providers before supplementing, and individuals with bleeding disorders or taking blood thinners require medical supervision. Generally, ubiquinol is well-tolerated across most populations, but personalized medical guidance is recommended for special populations.

### What does the current research show about ubiquinol's effectiveness for specific health conditions, and how robust is the evidence?

While ubiquinol has established biochemical mechanisms for energy production and antioxidant activity in cells, clinical evidence supporting its use for specific conditions remains limited and mixed in quality. Research on cardiovascular health, mitochondrial support, and statin side effects shows promise but often involves small sample sizes or preliminary findings rather than large, definitive trials. More high-quality clinical studies are needed to conclusively establish efficacy for specific health outcomes beyond its fundamental role in cellular energy metabolism.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*